nav Searchuser
Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

Bioceres Crop Solutions closes $42.5 m financing to accelerate global launch of HB4 technologyqrcode

Mar. 11, 2020

Favorites Print
Forward
Mar. 11, 2020
Bioceres Crop Solutions Corp. ("Bioceres" or the "Company") (NYSE American: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, recently announced the closing of $42.5 million secured convertible promissory notes due 2023 (the "Notes") in a private placement led by Boston-based Solel Partners LP. The Company intends to use proceeds to accelerate launch of its HB4 technology – a drought and salinity tolerance seed solution available for soybean and wheat crops. Next generation seed varieties integrating HB4 technology with proprietary seed-treatment biologicals are currently being multiplied under the EcoSoy™ and EcoWheat™ product denominations.

"With the issuance of these Notes we have put in place the necessary funding to transition HB4 crops’ acreage from the 'thousands' to the 'hundreds of thousands' over the next crop cycle, as well as accelerate breeding and business collaborations to access incremental geographies, with the main focus on the United States and Brazil," indicated Federico Trucco, Bioceres’ Chief Executive Officer.

"In addition to providing HB4-related working capital, this facility will help us improve our overall debt profile by terming-out maturities and reducing interest expenses, mainly by discontinuing inefficient sources of working capital. This transaction together with the February 14, 2020, public bond issuance of our subsidiary Rizobacter Argentina S.A., is part of an ongoing process to strengthen our balance sheet as we prepare to seize the growth opportunities that we have patiently built over many years" Commented Enrique Lopez Lecube, Chief Financial Officer of the Company.

"This transaction is also well aligned with our efforts towards increasing trading liquidity of our stock. Our commitment to strengthening our financial position and building value for our shareholders is underscored by what we are announcing today," concluded Mr. Lopez Lecube.

Picture 0/1200

More from AgroNews

Magazine

2020 Biologicals Special 2020 Formulation & Adjuvant Technology
Annual Review 2019 Chinese issue of Annual Review 2019
2019 CRO & CRAO Manual 2019 Market Insight
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.